Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study-Reference-Cited by-同舟云学术

Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study

Published:2014-10 Issue:3 Volume:176 Page:577-582
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Doi Masayuki,Nosaka Kazumasa,Miyoshi Toru,Iwamoto Mutsumi,Kajiya Masahito,Okawa Keisuke,Nakayama Rie,Takagi Wataru,Takeda Ko,Hirohata Satoshi,Ito Hiroshi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. The inflammatory response in myocardial infarction;Frangogiannis;Cardiovasc Res,2002

2. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein;Suleiman;J Am Coll Cardiol,2006

3. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction;Suleiman;Am J Med,2003

4. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24months of follow-up in patients under thrombolytic treatment;Pietila;Eur Heart J,1996

5. Inflammatory cytokines and postmyocardial infarction remodeling;Nian;Circ Res,2004

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized, double-blind, placebo-controlled clinical trial;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-29

2. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis;Food & Function;2024

3. Do patients benefit from omega-3 fatty acids?;Cardiovascular Research;2023-12

4. Enhanced Production of EPA-Derived Anti-Inflammatory Metabolites after Oral Administration of a Novel Self-Emulsifying Highly Purified EPA Ethyl Ester Formulation (MND-2119);Journal of Atherosclerosis and Thrombosis;2023-12-01

5. Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk;International Journal of Angiology;2023-11-24